10.1038/nrm2308 Nat
All this translates into an improvement in glycemic control and dyslipidemia, a reduction in blood pressure, weight, and ectopic visceral fat deposits, as well as inflammation and coagulation, which could translate into greater cardiovasculorenal protection with the use of these drugs
The bacterial names do not diagnose the patient Finding general information about sulfate-reducing bacteria does not prove that a specific person has hydrogen-sulfide SIBO, dysbiosis, or a microbiome imbalance requiring supplements or antibiotics
Glutathionecalled natures master antioxidantis a powerful defender against these attackers and is essential for good immune health
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 4 in 10 American adults and is closely linked to obesity, type 2 diabetes, and high blood pressure
Retatrutide may eventually have a clearer role, but early trial promise can change as larger studies include more people and longer observation